The Foxhall Research Unit currently has three active studies: 1. Injectable agent for severe psoriasis (closed to enrollment) 2. Oral medication for severe atopic dermatitis (open to enrollment) 3. Topical medication for contact dermatitis (open to enrollment) Please call 202-838-3016 if you would like more information regarding these studies.